Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances - Test2 - elhamkhani - TriplyDB

Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances

Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances

http://www.wikidata.org/entity/Q34650411

about

PDX1 associated therapy in translational medicine Do glucagonomas always produce glucagon?Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.Mixed serous neuroendocrine neoplasm of the pancreas: Case report and literature review.Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator Zollinger-Ellison syndrome: classical considerations and current controversies.Important of case-reports/series, in rare diseases: Using neuroendocrine tumors as an example.Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors.Multiple Endocrine Neoplasia: Genetics and Clinical Management.Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Histamine regulation of pancreatitis and pancreatic cancer: a review of recent findings.Sphincter of Oddi Function and Risk Factors for Dysfunction.Zollinger-Ellison syndrome: recent advances and controversies.Neuroendocrine tumours: the role of imaging for diagnosis and therapy.The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution.Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.Watery stools and metabolic acidosis.Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema.Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.PPoma Review: Epidemiology, Aetiopathogenesis, Prognosis and Treatment.Management of functional neuroendocrine tumors of the pancreas.Shape and Enhancement Characteristics of Pancreatic Neuroendocrine Tumor on Preoperative Contrast-enhanced Computed Tomography May be Prognostic Indicators.Assessing the short- and long-term outcomes after resection of benign insulinoma.Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.Rare malignant insulinoma with multiple liver metastases derived from ectopic pancreas: 3-year follow-up and literature review.

P2860

Q26744079-B02CAC1D-2111-498B-BE7A-57D65825AB49 Q26771665-B768F5C6-9E56-41AA-86C5-EBCE692A18F5 Q30491060-D7CA5B21-8944-4DA3-B5BA-985B6844A13D Q33590474-F5BD2AAD-C6C4-40D3-B029-565049968BEE Q33708663-CD4A6721-8156-4A91-8DDA-3C57A14FD53D Q33833281-C8F760AC-5469-4E6D-BC50-3B36F6E63623 Q34390574-4D6226CF-DA89-4FEB-8830-62E238A4B379 Q34520056-026A3AE4-14BC-4566-8C1B-A228E7DECA0E Q35713515-FDA2A77F-72FB-4FDF-B75A-B81107FCD16E Q36063577-B667E3D7-1C8B-4953-ADC1-B4C4D46079A7 Q36834005-B2E0FD00-4F2B-44F6-A8AD-78B1AAA0D9EF Q36849357-82A5B5C5-1112-4F4E-B1C2-0517D0A13B1F Q37584702-F3B249D9-8CAC-4DB0-839E-DF934FBD3332 Q37611638-7AE8BF0A-C86C-43A0-BBC0-4743E80A58E6 Q38150165-BFF1AA32-7BE7-4008-9CE0-73C07C84F9D1 Q38169928-97D3DCAB-2EC7-4956-AFDC-60FB1674A48F Q38358391-DE8B2A4E-E5D5-4EEF-8431-C1FDFE2D5D9E Q38457942-7BC6744D-BA29-4D4E-A330-1BA99698B86C Q38730927-A891D346-ACC9-4BC5-BB3D-9BBBE09D65F0 Q38931272-DA7AB19F-29C8-4593-95D9-761CAB9D005F Q38956091-9770D5C7-8A6B-45CC-933F-C5051E2E630B Q39016753-160332A2-3006-413D-81EE-E80F69D3523C Q39476073-F36E6C6E-F748-4C23-8DB1-10621A7EE88A Q45062413-9D252188-76DE-4FBE-BDB4-C3798F2E97A6 Q47732594-87F5AD61-B5B8-43C9-9C66-CC1475125BF0 Q48314384-FE70CEAF-AA7B-4EA3-910C-B565778CA8A2 Q49576212-9F8EAFB5-E5D7-4E89-8A09-F6FB7FBD8C1A Q50075239-53541210-7AC9-425E-BC51-942FAA0D4FD9 Q50086050-483FD98F-01D0-42C9-B271-B461488A9447 Q52599451-A311E900-C716-4392-A8AA-905D59A6BD85 Q52952850-7BA23C1A-04A1-4E25-9937-1E317C798B1B Q53043529-A200FAAA-C2A2-4D18-8145-FAEB600E9CC8 Q53296279-E80D1F4E-CD69-4200-A6F7-991CECA5C184 Q55076102-B24C0CBB-BD57-46FD-B242-2F5D6B8F9019

P2860

Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances

http://www.wikidata.org/entity/Q34650411

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@ast

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@en

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@nl

type

label

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@ast

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@en

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@nl

prefLabel

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@ast

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@en

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@nl

P1433

Q34650411-096E056E-C7F6-4104-8B15-0909418D12A8

P1476

Q34650411-B7C4AFBF-D53D-41F6-8531-503D0AE1B5AA

P2093

Q34650411-01CBF63F-7132-4A6E-8A8D-52DEFC259609

Q34650411-070D3696-E1D5-47A7-9D53-D7909FBC4BB7

Q34650411-46F3E0F9-01AD-4E70-BAE5-5482834DA2BA

P2860

Q34650411-0266CB2D-9D52-4A60-815B-B2D63858928B

Q34650411-02BF2257-4899-4F23-AD5F-FC953268B695

Q34650411-0605C4C3-3DA7-4575-BCBA-9D9041C62020

Q34650411-0A67036E-619F-4E26-A648-26938F0A4BC2

Q34650411-0B4ECE52-28B0-40B7-B2FF-C1E193839606

Q34650411-0C12E06D-4BFA-4CD4-9CFD-02C67B137207

Q34650411-10E3621B-0E39-4E4D-8F7D-43AE47963F4A

Q34650411-12D0B524-90AA-4EF5-B314-5C6C3AC14150

Q34650411-12D9ECA4-778B-4E36-82FB-2F916415D565

Q34650411-14B1DB3E-8AEF-4649-B36A-19B7DAC985E8

P304

Q34650411-ABC2E52C-6ED1-406D-B5F7-2EA86890E779

P31

Q34650411-39DAFD49-BAD1-4469-A7B8-0759575DDB59

P356

Q34650411-7C7373B5-B4A0-4949-883A-0EAE607D0A36

P433

Q34650411-5BC68043-7CEB-46FF-B24D-CA1D4B535995

P478

Q34650411-94423C6D-47EE-4383-B6EC-29BAA970050E

P577

Q34650411-C9848F02-1456-4A80-8C91-665722A83A5D

P5875

Q34650411-BA07C6F7-1B64-4DC2-A6B9-43C6644E008D

P698

Q34650411-88A10B98-43EF-4A5D-8C0D-35D86F9E57F5

P932

Q34650411-48E6AA7E-3222-46C4-85B0-480862FDE54E

P356

J.BPG.2012.12.003

P1433

Best Practice and Research: Clinical Gastroenterology

P1476

Pancreatic neuroendocrine tumo ...... nd medical treatment: advances

@en

P2093

Hisato Igarashi

http://www.w3.org/2001/XMLSchema#string

Robert T Jensen

http://www.w3.org/2001/XMLSchema#string

Tetsuhide Ito

http://www.w3.org/2001/XMLSchema#string

P2860

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies

Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor

Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms

von Hippel-Lindau disease

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

The tuberous sclerosis complex

Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma.

Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden.

P304

737-753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BPG.2012.12.003

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236199252

http://www.w3.org/2001/XMLSchema#string

P698

23582916

http://www.w3.org/2001/XMLSchema#string

P932

3627221

http://www.w3.org/2001/XMLSchema#string